Interleukin (IL)-33 Immunobiology in Asthma and Airway Inflammatory Diseases
-
2022/12/01
Details
-
Personal Author:
-
Description:Objective: Identify key features of IL-33 immunobiology important in allergic and nonallergic airway inflammatory diseases and potential therapeutic strategies to reduce disease burden. Data Sources: PubMed, clinicaltrials.gov Study Selections: A systematic and focused literature search was conducted of PubMed from March 2021 to December 2021 using keywords to either PubMed or BioMed Explorer including IL-33/ST2, genetic polymorphisms, transcription, translation, post-translation modification, nuclear protein, allergy, asthma, and lung disease. Clinical trial information on IL-33 was extracted from clinicaltrials.gov in August 2021. Results: In total, 72 publications with relevance to IL-33 immunobiology and/or clinical lung disease were identified (allergic airway inflammation/allergic asthma n = 26, non-allergic airway inflammation n = 9, COPD n = 8, lung fibrosis n = 10). IL-33 levels were higher in serum, BALF and/or lungs across inflammatory lung diseases. Eight studies described viral infections and IL-33 and 4 studies related to COVID-19. Mechanistic studies (n = 39) including transcript variants and post-translational modifications related to the immunobiology of IL-33. Single nucleotide polymorphism in IL-33 or ST2 were described in 9 studies (asthma n = 5, inflammatory bowel disease n = 1, mycosis fungoides n = 1, ankylosing spondylitis n = 1, coronary artery disease n = 1). Clinicaltrials.gov search yielded 84 studies of which 17 were related to therapeutic or biomarker relevance in lung disease. Conclusion: An integral role of IL-33 in the pathogenesis of allergic and nonallergic airway inflammatory disease is evident with several emerging clinical trials investigating therapeutic approaches. Current data support a critical role of IL-33 in damage signaling, repair and regeneration of lungs. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0277-0903
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Volume:59
-
Issue:12
-
NIOSHTIC Number:nn:20064597
-
Citation:J Asthma 2022 Dec; 59(12):2530-2538
-
Contact Point Address:Rohit Gaurav, Department of Internal Medicine, Division of Allergy and Immunology, 985910 Nebraska Medical Center, Omaha, NE 68198-5910, USA
-
Email:rohit.gaurav@unmc.edu
-
Federal Fiscal Year:2023
-
NORA Priority Area:
-
Performing Organization:University of Nebraska Medical Center - Omaha
-
Peer Reviewed:True
-
Start Date:20110901
-
Source Full Name:Journal of Asthma
-
End Date:20270831
-
Collection(s):
-
Main Document Checksum:urn:sha-512:da0f07312ca67599b1545f09d47201006f96c7314f8fa9e24423de23c32ea282cb90ff6e91f5c8f135ae4d97aa1b9beb83fbb37fcea77d5881cfa31dc4c28b68
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like